Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug2789 | Remote Cognitive Behavioral Therapy for Insomnia Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D020920 | Dyssomnias NIH | 0.38 |
D020447 | Parasomnias NIH | 0.35 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
In this study, Investigators plan to study the effect of using the geko™ device in COVID-19 patients and measure patient outcomes such as ICU admission and death. The findings of this study have the potential to decrease the complications seen in COVID-19 infections.
Description: The impact of the geko™ device on patient outcomes in critically ill COVID-19 patients.
Measure: Morbidity Time: From date of admission to discharge from hospital assessed up to a 100 weeks whichever comes first.Description: The impact of the geko™ device on patient outcomes in critically ill COVID-19 patients.
Measure: Mortality Time: From date of admission to discharge from hospital or death in hospital assessed up to a 100 weeks whichever comes first.Description: Incidence of any unexpected adverse events will be measured. Adverse event reporting will be done based on the Canadian Association of Research Ethics Boards Guidance on Reporting of Unanticipated Problems including Adverse Events to Research Ethics Boards in Canada.
Measure: Incidence of unexpected adverse events Time: From admission to discharge from hospital or death in hospital, assessed up to a 100 weeks whichever comes first.Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports